InnSight Technology, Inc was established in 2014. The company is comprised of engineers, ophthalmologists and business experts who are focused on delivering translatable technology from the lab to the clinics to improve ocular care. To achieve this goal, the company is working on the development of the OcuCheck™ a novel point-of-service device that can evaluate the integrity of anterior ocular wounds and could be used to aid in the diagnosis of open globe injuries and post surgical patients.
“The emergence of OcuCheck…offers significant hope and advantage to emergency or field-based providers to gauge the presence of significant ocular trauma”
– John Rimmer, D.O., Medical Site Director, Emergency Medicine, Hoboken University Medical Center, NJ
“I believe that this device [OcuCheck] can have a positive impact on patients throughout the world”
– Joel Schuman, M.D., F.A.C.S, Chairman, Department of Ophthalmology, University of Pittsburgh Medical Center, PA
“This technology promises to be a significant improvement in the diagnosis and treatment of eye injuries”
– Timothy C. Hoerr, CEO, Serra Ventures, LLC, Managing Partner of Serra Capital II, LP